Navigation Links
New street drug 'bath salts' packs double punch
Date:2/23/2012

acerbate the effect of either drug applied alone," said De Felice.

The researchers began this particular project as part of a larger study on how amphetamine and METH affect the human dopamine transporter molecule. They made the novel finding that both chemicals create long-lasting effects that endure 30 minutes or more after the drugs are removed. This initial research continued with cathinone (CATH), which is a naturally occurring compound found in the khat shrub (Catha edulis). The drugs found in bath salts (MEPH and MDPV) are synthetic derivatives of CATH.

"The stimulant and blocker features of these drugs have been studied previously," said De Felice, "but the evidence for long-lasting stimulation by MEPH and inhibition by MDPV is novel. It also is in some sense unexpected that two structurally similar agents could act oppositely at the dopamine transporter."

The researchers do not yet know why these drugs have a persistent effect. They also don't understand the fundamental reason why two structurally similar drugs act oppositely on the dopamine transporter.

"There also are many questions on the meaning of these findings for the dozens of other illicit synthetic drugs that have found their way to the street," concludes De Felice. "We do suspect, however, that the combination that is found in bath salts could be behind its powerful physiological and neurological effect on users."

According to the American Association of Poison Control Centers, there were more than 6,000 calls to poison control centers pertaining to bath salts in 2011, more than ten times the number in 2010. Reported symptoms of exposure include increased blood pressure, increased heart rate, agitation, hallucinations, extreme paranoia, and delusions.

The presentation, "'Bath Salts': A synthetic cathinone whose two major components act similar to methamphetamine and cocaine on the human dopamine transporter," is at 9:15 a.m. on Monday, F
'/>"/>

Contact: Ellen R. Weiss
eweiss@biophysics.org
240-290-5606
American Institute of Physics
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. MainStreet MD Launches Personal Safety Solutions for Children and Seniors Built On SensorLogic's Cloud Computing Platform
2. Summer Street Capital Announces the Addition of Barry D. Freeman as Healthcare Advisory Partner
3. Earth Class Mail™ Introduces Miami and Chicago Street Addresses
4. Study Shows You Don't Need Wall Street Sized Bonuses to Raise Employee Morale
5. San Francisco AIDS Foundation Introduces HIV Testing to Sixth Street
6. New York Personal Injury Attorney Interprets Increase in Tickets for Cyclists as Effort to Make Streets Safer
7. Global Leader Readied For Healthy Aging Boom, Targets Wall Street With New Center In Trump Building
8. Trikz Streetball Basketball iTunes App Promotion: Only $.99 to Unlock All Content for the iPhone, iPod Touch, and iPad
9. Sam's Club Tests Online Small Business Loan Program for Main Street
10. Street outreach workers an important tool for violence prevention and intervention
11. Diabetes, Depression Can Be Two-Way Street
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... teaching hospital in Ireland has shown than many of them ... minimise the risk of entrapment. The report, published online in ... need for careful selection of patients for whom bedrails are ... and maintenance of hospital bed systems. , Bedrails are commonly ... However, although the risk for any individual is extremely low, ...
(Date:7/30/2014)... July 30, 2014 Victory Medical ... proud to announce the launch of a pediatric unit ... general surgery. The doctors working in the pediatrics departments ... infants, children, and adolescents. Dr. Timothy Cole, Dr. Dale ... McDuffie, Dr. Neelesh Mehendale, and Dr. Nicholas Peiffer lead ...
(Date:7/30/2014)... 30, 2014 Dialogic Inc. ... announced that DollarPhone, the largest privately owned calling ... Dialogic® ControlSwitch™ softswitch to offer enhanced ... portability (LNP) to both its wholesale and prepaid ... is able to power DollarPhone’s network infrastructure, allowing ...
(Date:7/30/2014)... 30, 2014 A formal complaint ... Office against the maker of the dialysis products ... Medical Care defrauded the state, its residents, physicians ... dialysates, before they were recalled in 2012. There ... these products pending in the U.S. District Court, ...
(Date:7/30/2014)... -- ,Middle-aged adults with a history of alcohol abuse ... develop severe memory problems later in life, according to ... findings could help doctors identify those at risk for ... drinking. "We already know there is an association ... -- that understanding is based on asking older people ...
Breaking Medicine News(10 mins):Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 2Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 3Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 2Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 3Health News:Adults Who've Abused Alcohol May Be at Risk for Memory Problems 2
... Children hospitalized with pandemic H1N1 influenza in 2009 ... medical conditions than children hospitalized with seasonal influenza ... to be presented Tuesday, May 4 at the ... British Columbia, Canada. Population-based surveillance of ...
... physicians for providing better care to patients could end ... those belonging to racial and ethnic minorities, according to ... under a typical pay-for-performance program medical practices that serve ... practices, a result of existing gaps in the quality ...
... opioid prescriptions, leading to increased misuse, serious injuries, ... physicians and surgeons to create a new guideline ... an article in CMAJ ( Canadian ... http://www.cmaj.ca/embargo/cmaj100187.pdf . Opioid use in Canada has ...
... ... Alert #80-04, “Surveillance and Detention Without Physical Examination of Surgeon’s and Patient Examination Gloves” (IA ... and/or shippers on Import Alert #80-04; two of which were listed multiple times and one ... ...
... "extraordinarily high prevalence" of vitamin D deficiency a potential ... new Cincinnati Children,s Hospital Medical Center study. The vitamin ... preventing exposure of the skin to sunlight and subsequent ... in the Center for Global Child Health at Cincinnati Children,s ...
... has been awarded a $10 million grant from the National ... Urban Health Equity. The aim of the Center is to ... heart and lung disease affecting inner city residents, in particular ... have persisted or worsened in the past two decades, despite ...
Cached Medicine News:Health News:H1N1 influenza hits older children 2Health News:Pay-for-performance programs may worsen medical disparities, study finds 2Health News:Pay-for-performance programs may worsen medical disparities, study finds 3Health News:Many Non-U.S. Firms Affected by U.S. FDA Import Alert 80-04 for Medical Glove Manufacturing Defects, According to FDAImports.com, LLC 2Health News:Many Non-U.S. Firms Affected by U.S. FDA Import Alert 80-04 for Medical Glove Manufacturing Defects, According to FDAImports.com, LLC 3Health News:Vitamin D deficiency in pregnant Arab women requires urgent attention 2Health News:NIH awards $10 million to Rush University Medical Center to address health disparities 2Health News:NIH awards $10 million to Rush University Medical Center to address health disparities 3Health News:NIH awards $10 million to Rush University Medical Center to address health disparities 4
(Date:7/29/2014)... 29, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... two healthcare conferences during the third quarter, the 2014 ... Global Healthcare 2014 Conference.  Alexza,s corporate presentation will be ... on each event are below: , 2014 ... in Boston , MA.  The format ...
(Date:7/29/2014)... Inc. (NYSE: CVD ) today reported results ... revenue was $639 million, representing 8.0% growth from the ... company reported earnings of $0.29 per diluted share in ... per diluted share of $0.95, up 21.5% over the ... impairment charges totaling $52.6 million, or $0.61 per share, ...
(Date:7/29/2014)... New technology in the form of a ... see and assess brain tissue more clearly while treating ... who released their findings today at the Society of ... Colorado Springs, CO. ... a specialty that facilitates stroke treatment by navigating a ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 2Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 3Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 4Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 5Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 6Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 7Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 8Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 9Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 10Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 11Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 12Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 13Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 14Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 15Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 16Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 17Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 18Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 19Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 20Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 21Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 22Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 23Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million 24New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3
... First Advantage , a leading global provider ... that it has made a significant minority investment in ... Workstream was announced by Todd Mavis, CEO of First ... supplier of talent acquisition and talent management solutions and ...
... Minimally Invasive Devices, Inc. , (MID) has been ... laparoscopic visualization system.  This certification is mandatory for sale ... The FloShield system provides for an uninterrupted ... the insufflator to defog and deflect debris from the ...
Cached Medicine Technology:First Advantage Invests in Workstream Inc. 2First Advantage Invests in Workstream Inc. 3Minimally Invasive Devices, Inc. Awarded CE Mark for FloShield™ 2
... requirements of blood banking and processing ... meets American Association of Blood Banks ... and U.S. Food & Drug Administration ... platelet incubators feature alarm systems that ...
Refrigerator specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997....
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
... assay is a direct competitive EIA ... in human serum or plasma. A ... proteins, making it available for antibody ... anti-Testosterone antibody linked to fluorescein isothiocyanate ...
Medicine Products: